§ Same category · GLP-1 / metabolic peptides
Retatrutide vs Tesofensine
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Retatrutide
6
vendors tracked
from $2.60/mg
Tesofensine
0
vendors tracked
Retatrutide
Triple GCG/GIP/GLP-1 agonist
B
Operational$49.99
$5.00/mg
In stock◎ Best $/mg
Watch
$103.99
$10.40/mg
In stock▲ 108.0% vs best
Watch
$129.99
$13.00/mg
In stock▲ 160.0% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Welli Labs US | B | Operational | $49.99 ◎ Best $/mg | $5.00 | In stock | Buy with code → | |
| Australian Peptide Store AU | B- | Watch | $103.99 ▲ 108.0% | $10.40 | In stock | Visit → | |
| Felix Chemical Supply US | B- | Watch | $129.99 ▲ 160.0% | $13.00 | In stock | Visit → |
Sort:
Last crawl 2026-11-12Sort:
2026-11-12Tesofensine
Triple monoamine reuptake inhibitor
No current listings at 1mg.
About Retatrutide
An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.
About Tesofensine
A serotonin-noradrenaline-dopamine reuptake inhibitor studied for obesity. Approved for obesity in Mexico; investigational elsewhere.